Sign up to view this video Join Now Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Aligning Trials with Patient-Lived Experiences AI-Driven Patient Identification and Recruitment Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials
Sign up to view this video Join Now Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Previous Opening Keynote: The Future of Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Aligning Trials with Patient-Lived Experiences AI-Driven Patient Identification and Recruitment Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials
